{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33900695",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "06",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1615/CritRevImmunol.2020035633"
    ],
    "Journal": {
      "ISSN": "1040-8401",
      "JournalIssue": {
        "Volume": "40",
        "Issue": "6",
        "PubDate": {
          "Year": "2020"
        }
      },
      "Title": "Critical reviews in immunology",
      "ISOAbbreviation": "Crit Rev Immunol"
    },
    "ArticleTitle": "COVID-19 and Strategies for Its Therapeutics.",
    "Pagination": {
      "StartPage": "513",
      "EndPage": "526",
      "MedlinePgn": "513-526"
    },
    "Abstract": {
      "AbstractText": [
        "Currently the epidemic of SARS-CoV-2-caused COVID-19 is a major threat to global public health. The latest clinical data, laboratory results, and autopsy information are summarized herein to provide a brief review of the significant issues surrounding SARS-CoV-2 and COVID-19. In this review, we also cover research on the ways in which the virus enters the human body, general clinical symptoms, immunopathological responses in severe cases of COVID-19, and the issues surrounding the potential therapeutic responses to the illness."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, China."
          }
        ],
        "LastName": "Ma",
        "ForeName": "Fayang",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, China."
          }
        ],
        "LastName": "Gu",
        "ForeName": "Tingxuan",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, China."
          }
        ],
        "LastName": "Zhao",
        "ForeName": "Simin",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, China; Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, China; Cancer Chemoprevention International Collaboration Laboratory, Zhengzhou, China."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Kangdong",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, China."
          }
        ],
        "LastName": "Dong",
        "ForeName": "Zigang",
        "Initials": "Z"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Crit Rev Immunol",
    "NlmUniqueID": "8914819",
    "ISSNLinking": "1040-8401"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pathology",
        "therapy",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Management"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Susceptibility"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}